Concepedia

Laurence Catley

LC

34

Publications

4.9K

Citations

30

H-Index

2001

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Novartis (Switzerland)

VA Boston Healthcare System

Brigham and Women's Hospital

Laurence Catley is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

2001–2013

34

Publications

34

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Paul G. Richardson, Robert Schlossman, Edie Weller et al. · Blood · 2002 · 799 citations · Full text

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

Richard LeBlanc, Laurence Catley, Teru Hideshima et al. · PubMed · 2002 · 456 citations

, , +21

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

Teru Hideshima, Laurence Catley, Hiroshi Yasui et al. · Blood · 2006 · 420 citations · Full text

Immunomodulatory drug costimulates T cells via the B7-CD28 pathway

Richard LeBlanc, Teru Hideshima, Laurence Catley et al. · Blood · 2003 · 281 citations

NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma

Laurence Catley, Ellen Weisberg, Yu-Tzu Tai et al. · Blood · 2003 · 219 citations · Full text

Rows per page

1–5 of 34